Feature | March 20, 2018| Dave Fornell

Most Popular Cardiology Technology Content in February 2018 on DAIC

Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery.

Edwards Lifesciences received European CE mark clearance for its self-expanding Centera transcatheter aortic valve replacement (TAVR) device for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery. This was the top structural heart story of the month of February 2018.

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of February 2018. This is based on website analytics of the month’s 176,232 pageviews:

1. Philips Recalls HeartStart MRx Defibrillator, Defect May Cause Device Failure

2. Medtronic Recalls CRT-Ds and ICDs Due to Manufacturing Error Preventing Electrical Shock Delivery

3. FDA Expands Impella Indication for High-risk PCI Procedures

4. Current State of Bioresorbable Stent Technology

5. CT Calcium Scoring for Heart Disease May Lead to Prevention, Treatments

6. Edwards Lifesciences Self Expanding TAVR Valve Gains European Approval

7. Recently Introduced Angiography Imaging Technology

8. New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

9. Advances and Trends in Vascular Closure Devices

10. Links to Echocardiography Educational Videos

11. Abbott Begins Enrollment in XIENCE 28 GLOBAL DAPT Trial

12. What Trends are Ahead in Cardiovascular Medicine in 2018?

13. ACC 2018 Late-Breaking Trials

14. Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled

15. New Technologies to Improve Atrial Fibrillation Ablation

 

Top Videos in February 2018:

1. VIDEO: History of Radial Artery Access

2. VIDEO: Ohio State University Introduces ECMO Protocol for Cardiac Arrest

3. VIDEO: Wearable Health Monitors and Apps at the 2018 Consumer Electronics Show

4. VIDEO: Editor's Choice of the Most Innovative New Imaging Technology at RSNA 2017

5. VIDEO: Editor's Choice of the Most Innovative New Technologies at TCT 2017

 

Related Content

Most Popular Cardiology Topics of 2017

Most Popular Cardiology Technology Content in January 2018 on DAIC

Most Popular Cardiology Technology Content on DAIC in December 2017

Most Popular Cardiac Technology Content in November 2017 on DAIC

 

 

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Overlay Init